These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 9973449)
1. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling. Faith A; Akdis CA; Akdis M; Joss A; Wymann D; Blaser K J Immunol; 1999 Feb; 162(3):1836-42. PubMed ID: 9973449 [TBL] [Abstract][Full Text] [Related]
2. Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56(lck) and ZAP-70 tyrosine kinase activities. Faith A; Akdis CA; Akdis M; Simon HU; Blaser K J Immunol; 1997 Jul; 159(1):53-60. PubMed ID: 9200438 [TBL] [Abstract][Full Text] [Related]
3. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13. Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575 [TBL] [Abstract][Full Text] [Related]
4. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. Akdis CA; Akdis M; Blesken T; Wymann D; Alkan SS; Müller U; Blaser K J Clin Invest; 1996 Oct; 98(7):1676-83. PubMed ID: 8833918 [TBL] [Abstract][Full Text] [Related]
5. Impaired secretion of interleukin-4 and interleukin-13 by allergen-specific T cells correlates with defective nuclear expression of NF-AT2 and jun B: relevance to immunotherapy. Faith A; Richards DF; Verhoef A; Lamb JR; Lee TH; Hawrylowicz CM Clin Exp Allergy; 2003 Sep; 33(9):1209-15. PubMed ID: 12956740 [TBL] [Abstract][Full Text] [Related]
6. Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells. Tsitoura DC; Verhoef A; Gelder CM; O'Hehir RE; Lamb JR J Immunol; 1996 Sep; 157(5):2160-5. PubMed ID: 8757342 [TBL] [Abstract][Full Text] [Related]
7. Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand. Verhoef A; Lamb JR J Immunol; 2000 Jun; 164(11):6034-40. PubMed ID: 10820288 [TBL] [Abstract][Full Text] [Related]
8. Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands. Tsitoura DC; Holter W; Cerwenka A; Gelder CM; Lamb JR J Immunol; 1996 Apr; 156(8):2801-8. PubMed ID: 8609399 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants. Akdis CA; Blesken T; Wymann D; Akdis M; Blaser K Eur J Immunol; 1998 Mar; 28(3):914-25. PubMed ID: 9541587 [TBL] [Abstract][Full Text] [Related]
10. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production. Blaser K Adv Exp Med Biol; 1996; 409():295-303. PubMed ID: 9095257 [TBL] [Abstract][Full Text] [Related]
11. Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide. Salazar E; Zaremba S; Arlen PM; Tsang KY; Schlom J Int J Cancer; 2000 Mar; 85(6):829-38. PubMed ID: 10709104 [TBL] [Abstract][Full Text] [Related]
12. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Carballido JM; Faith A; Carballido-Perrig N; Blaser K Eur J Immunol; 1997 Feb; 27(2):515-21. PubMed ID: 9045925 [TBL] [Abstract][Full Text] [Related]
13. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding. Tao X; Grant C; Constant S; Bottomly K J Immunol; 1997 May; 158(9):4237-44. PubMed ID: 9126985 [TBL] [Abstract][Full Text] [Related]
14. Peptide antagonists inhibit proliferation and the production of IL-4 and/or IFN-gamma in T helper 1, T helper 2, and T helper 0 clones bearing the same TCR. Dittel BN; Sant'Angelo DB; Janeway CA J Immunol; 1997 May; 158(9):4065-73. PubMed ID: 9126964 [TBL] [Abstract][Full Text] [Related]
15. Altered peptide ligands can modify the Th2 T cell response to the immunodominant 161-175 peptide of LACK (Leishmania homolog for the receptor of activated C kinase). Jensen KD; Sercarz EE; Gabaglia CR Mol Immunol; 2009 Jan; 46(3):366-74. PubMed ID: 19042022 [TBL] [Abstract][Full Text] [Related]
16. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration. Carballido JM; Carballido-Perrig N; Terres G; Heusser CH; Blaser K Eur J Immunol; 1992 Jun; 22(6):1357-63. PubMed ID: 1601030 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of protein tyrosine kinases and their phosphorylation in murine Th1 cells anergized with class II MHC-peptide complexes. Yu SC; Nag B Immunol Cell Biol; 1997 Jun; 75(3):295-302. PubMed ID: 9243296 [TBL] [Abstract][Full Text] [Related]
18. Determinants and mechanisms of human immune responses to bee venom phospholipase A2. Blaser K; Carballido J; Faith A; Crameri R; Akdis C Int Arch Allergy Immunol; 1998 Sep; 117(1):1-10. PubMed ID: 9751842 [TBL] [Abstract][Full Text] [Related]
19. Differential signaling and hierarchical response thresholds induced by an immunodominant peptide of myelin basic protein and an altered peptide ligand in human T cells. Crowe PD; Boehme SA; Wong T; Gaur A; Sidney J; Sette A; Conlon PJ Hum Immunol; 1998 Nov; 59(11):679-89. PubMed ID: 9796736 [TBL] [Abstract][Full Text] [Related]